denosumab
daiichi sankyo,amgen
['denosumab']
wittoek et al. 48-week rct of denosumab in erosive hand oa. prevents structural progression! #acr22 abstr#l05 #acrbest 
Rheumatologist @stjamesdublin , Associate Professor @tcddublin , Acute Medicine, Vasculitis, ILD, Retired @Emeunet Executive Committee member, @rheum_covid CASC